Boston Private Bank & Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Boston Private Bank & Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$483K	Buy	7,756 +182	+2%	+$10.6K	0.02%	302
2014 Q4	$436K	Sell	7,574 -835	-10%	-$46.5K	0.02%	313
2014 Q3	$452K	Hold	8,409	–	–	0.02%	307
2014 Q2	$441K	Sell	8,409 -1,880	-18%	-$96.1K	0.02%	310
2014 Q1	$544K	Buy	10,289 +340	+3%	+$15.7K	0.03%	283
2013 Q4	$399K	Buy	9,949 +3,278	+49%	+$129K	0.02%	310
2013 Q3	$252K	Sell	6,671 -4,973	-43%	-$194K	0.01%	356
2013 Q2	$456K	Buy	+11,644	New	+$453K	0.03%	282

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Boston Private Bank & Trust's TEVA Position: Q1 2015 in Review

Boston Private Bank & Trust increased its Teva Pharmaceuticals (TEVA) stake by 2.4% in Q1 2015, buying an estimated $10.6K and bringing the position to 7,756 shares worth $483K. The position accounts for 0.02% of the portfolio, ranked #302.

Boston Private Bank & Trust first reported a position in TEVA in Q2 2013 and has held it in 8 quarters since. The position peaked at $544K in Q1 2014. 822 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.

Boston Private Bank & Trust held 7,756 shares of Teva Pharmaceuticals worth $483K as of Q1 2015.
Boston Private Bank & Trust bought 182 Teva Pharmaceuticals shares in Q1 2015, an estimated $10.6K.
Teva Pharmaceuticals made up 0.02% of Boston Private Bank & Trust's portfolio in Q1 2015, its #302 holding.
Boston Private Bank & Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 8 quarters since.
Boston Private Bank & Trust's Teva Pharmaceuticals position peaked at $544K in Q1 2014.
822 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.